MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

22 Aug 2023 Evaluate

Glenmark Pharmaceuticals has informed that it enclosed a Press Release issued by its wholly owned subsidiary company Glenmark Pharmaceuticals Inc., USA relating to entering into an agreement with U.S. Department of Justice, Antitrust Division (DOJ).

The above information is a part of company’s filings submitted to BSE. 

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..